Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY?OUTCOMES.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY?OUTCOMES.
Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY?OUTCOMES. J Am Coll Cardiol. 2020 02 04; 75(4):448-451.
View in:
PubMed
subject areas
Acute Coronary Syndrome
Antibodies, Monoclonal, Humanized
Anticholesteremic Agents
Cholesterol, LDL
Follow-Up Studies
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Time Factors
Treatment Outcome
authors with profiles
Robert Harrington